A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of AG2304T and AG2304R

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 158 participants.

Also called NCT06717360

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 158 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT06717360
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT06717360. Randomized; quadruple masking; primary purpose treatment. Start 2024-09-30 (actual); primary completion 2025-07-10 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of AG2304T and AG2304R
Condition
Hypercholesterolemia
Intervention (Drug)
AG2304T
Intervention (Drug)
AG2304R
Lead sponsor
Ahn-Gook Pharmaceuticals Co.,Ltd (class: industry)

Record details

Record id
cardio:ct-nct06717360
Content hash
346fcad270a22c9ad928727564935738af6eb71a500e418eb88c0cdcc394d7bc